Chemotherapy for a malignant peripheral nerve sheath tumor: A case report
Malignant peripheral nerve sheath tumors (MPNSTs) are uncommon and aggressive soft-tissue sarcomas. They are difficult to manage due to their aggressiveness and limitations in early diagnosis and management. Complete surgical resection with or without adjuvant radiotherapy is the most effective treatment for patients with primary disease, whereas in those with metastatic disease, cytotoxic chemotherapy is beneficial. We herein present the case of a woman who complained of severe lower back pain. Computed tomography and magnetic resonance imaging revealed multiple bone and lung lesions. The patient underwent a bone lesion biopsy and was diagnosed with an advanced MPNST, which was appropriately treated with systemic chemotherapy.
- Cai Z, Tang X, Liang H, Yang R, Yan T, Guo W. Prognosis and risk factors for malignant peripheral nerve sheath tumor: A systematic review and meta-analysis. World J Surg Oncol. 2020;18:257. doi: 10.1186/s12957-020-02036-x
- Sobczuk P, Teterycz P, Czarnecka AM, et al. Systemic treatment for advanced and metastatic malignant peripheral nerve sheath tumors-a sarcoma reference center experience. J Clin Med. 2020;9(10):3157. doi: 10.3390/jcm9103157
- Knight SWE, Knight TE, Santiago T, Murphy AJ, Abdelhafeez AH. Malignant peripheral nerve sheath tumors-a comprehensive review of pathophysiology, diagnosis, and multidisciplinary management. Children (Basel). 2022;9(1):38. doi: 10.3390/children9010038
- Farid M, Demicco EG, Garcia R, et al. Malignant peripheral nerve sheath tumors. Oncologist. 2014;19(2):193-201. doi: 10.1634/theoncologist.2013-0328
- Mehren M von, Kane JM, Agulnik M, et al. Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(7):815-833. doi: 10.6004/jnccn.2022.0035
- Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006
- Kroep JR, Ouali M, Gelderblom H, et al. First-line chemotherapy for Malignant Peripheral Nerve Sheath Tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: An EORTC Soft Tissue and Bone Sarcoma Group study. Ann Oncol. 2011;22(1):207-214. doi: 10.1093/annonc/mdq338